Poland· PL-100013117

Catalin

A other ophthalmologicals product containing pirenoxinum, registered in Poland by Senju Poland Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.

ATC S01XA

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCatalinATCS01XAREGISTER NO.PL-100013117PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Pirenoxinum is registered in 2 of 19 countries.

Countries holding a registration under ATC S01XA (other ophthalmologicals), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Pirenoxinum · ATC S01XA

2 / 19 countries

  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pirenoxinum
Manufacturer
Senju Poland Sp. z o.o.
Country
Poland (PL)
ATC code
S01XA
ATC class
Other ophthalmologicals
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990334315

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pirenoxinum in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pirenoxinum products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Portugal · Clarvisan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5f696d8-8e54-4630-8bc3-d97609615b4f
GET /v1/drugs/f5f696d8-8e54-4630-8bc3-d97609615b4f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletka i rozpuszczalnik do sporządzania kropli do oczu",
  "source": "urpl",
  "strength": "0,75 mg",
  "packaging": "05909990334315 ¦ Rp ¦ 2331\n1 tabl. 0,75 mg ¦ 1 butelka 15 ml rozp.",
  "substance": "Pirenoxinum natricum 0.85 mg",
  "common_name": "Pirenoxinum",
  "pl_product_id": "100013117",
  "pozwolenie_nr": "03343",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about pirenoxinum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.